Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 21;11(4):e200284.
doi: 10.1212/NXG.0000000000200284. eCollection 2025 Aug.

More Than APOE: Genetic Predictors in Alzheimer Disease in APOE ε3 Carriers

Nils Peters  1   2 , Paul G Unschuld  3   4
Affiliations
Editorial

More Than APOE: Genetic Predictors in Alzheimer Disease in APOE ε3 Carriers

Nils Peters et al. Neurol Genet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

N. Peters is a member of the executive board of the Swiss Society of Hypertension, the dementia task force of the Swiss Neurological Society, and the dementia committee of the European Stroke Organisation. P.G. Unschuld is a member of the executive board of the Swiss Society of Geriatric Psychiatry and of the Swiss Society of Neurology. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

Comment in

References

    1. Shen J, Kelleher RJ 3rd. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA. 2007;104(2):403-409. doi: 10.1073/pnas.0608332104 - DOI - PMC - PubMed
    1. Guerreiro R, Wojtas A, Bras J, et al.; Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117-127. doi: 10.1056/NEJMoa1211851 - DOI - PMC - PubMed
    1. Mattsson N, Groot C, Jansen WJ, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement. 2018;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009 - DOI - PubMed
    1. Kagerer SM, Awasthi S, Ripke S, et al. Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms. Alzheimers Dement. 2024;16(1):e12504. doi: 10.1002/dad2.12504 - DOI - PMC - PubMed
    1. Ramanan V, Heckman M, Hofrenning E, et al. Beyond APOE: combating genetic heterogeneity for polygenic prediction of susceptibility to brain amyloid-β deposition. Neurol Genet. 2025;11(4):e200266. doi: 10.1212/NXG.0000000000200266 - DOI

Publication types

LinkOut - more resources